Medicine

STOCKHOLM, Nov. 7, 2023 /PRNewswire/ -- The shareholders in Medivir AB (publ) reg. no. 556238-4361 (the "Company") are hereby convened to the extraordinary general meeting, which will be held on Friday 1 December 2023, at 10.00 CET at Helio GT30, Grev Turegatan 30, Stockholm,...

WeightWatchers teamed up with Vanderpump Rules' Peter Madrigal to help shake and stir things up at BravoCon 2023, in Las Vegas, NV.LAS VEGAS, Nov. 7, 2023 /PRNewswire/ -- On November 4th, Peter Madrigal served up WeightWatchers points-friendly cocktail menu on the WW Points Party...

DUBLIN, Nov. 7, 2023 /PRNewswire/ -- Alkermes plc (Nasdaq: ALKS) announced today that management will participate in a fireside chat at the Jefferies London Healthcare Conference on Tuesday, Nov. 14, 2023 at 12:00 p.m. ET (5:00 p.m. GMT). The live webcast may be accessed...

Third quarter 2023 Total Revenue of $28.1 million which includes record TAVALISSE® net product sales of $24.5 million and REZLIDHIA® net product sales of $2.7 million New data on olutasidenib in mIDH1 relapsed or refractory acute myeloid leukemia to be presented at ASH Annual Meeting...

Compelling efficacy signal in favor of larsucosterol in the key secondary endpoint of mortality at 90 days.  Clinically relevant reduction in 90-day mortality of 41% for 30 mg dose and 35% for 90 mg dose compared with standard of care (SOC) Numerical improvement in...

Reports Total Revenues of $3.94 Billion; U.S. GAAP Net Earnings of $332 Million; Adjusted EBITDA of $1.36 Billion; U.S. GAAP Net Cash Provided by Operating Activities of $834 Million; and Free Cash Flow of $738 Million for the Quarter Strong Results Signal Continuation of Growth...